Literature DB >> 19162224

Living environment of persons with severe epilepsy and intellectual disability: a prospective study.

Willeke van Blarikom1, In Y Tan, Albert P Aldenkamp, Adriaan Th G van Gennep.   

Abstract

We studied a population with intellectual disability (ID) and epilepsy and analyzed aspects of the living environment. Using an epilepsy impact score (EPIEK, the Epilepsy Impact Scale Kempenhaeghe), we found that epilepsy is more severe in younger persons than in older persons until about age 60 years. Individuals with more adaptive behavior had less severe epilepsy. Compared with persons with ID, the subjects in this study had fewer sensory problems and many more mobility problems, and more often saw a general practitioner. We concluded that people with severe epilepsy and ID have, in some ways, the same needs as people with only ID, and yet, in other ways (development of adaptive skills and aspects of living environment), distinctly different needs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19162224     DOI: 10.1016/j.yebeh.2008.12.021

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  3 in total

1.  A sector-wide response to national policy on client-centred care and support: a document analysis of the development of a range of instruments to assess clients' experiences in the care and support for people with (intellectual) disabilities.

Authors:  Petri J C M Embregts; Kees Ahaus; Mirella Minkman; Henk Nies; Pauline Meurs
Journal:  BMC Health Serv Res       Date:  2021-12-04       Impact factor: 2.655

2.  Odour detection in children and young people with profound intellectual and multiple disabilities.

Authors:  Geneviève Petitpierre; Juliane Dind; Catherine De Blasio; Germaine Gremaud
Journal:  J Appl Res Intellect Disabil       Date:  2021-12-03

3.  Adaptive skills and somatization in children with epilepsy.

Authors:  Nichole Wicker Villarreal; Cynthia A Riccio; Morris J Cohen; Yong Park
Journal:  Epilepsy Res Treat       Date:  2014-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.